# Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-nivolumab-in-previously-treated-patients-with-non-small/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daichi Fujimoto,Hiroshige Yoshioka,Yuki Kataoka,Takeshi Morimoto,Young Hak Kim,Keisuke Tomii,Tadashi Ishida,Masataka Hirabayashi,Satoshi Hara,Manabu Ishitoko,Yasushi Fukuda,Moon Hee Hwang,Naoki Sakai,Motonari Fukui,Hitoshi Nakaji,Mitsunori Morita,Tadashi Mio,Takehiro Yasuda,Takakazu Sugita,Toyohiro Hirai |
| Citations | 150 |
| DOI | 10.1016/j.lungcan.2018.02.017 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2791535137 |
| PMID | 29656747 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Daichi Fujimoto](https://scholariq.org/researchers/daichi-fujimoto/)
- [Yuki Kataoka](https://scholariq.org/researchers/yuki-kataoka/)
- [Takeshi Morimoto](https://scholariq.org/researchers/takeshi-morimoto/)

## Paper journal

- [Lung Cancer](https://scholariq.org/journals/lung-cancer/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.